436
Participants
Start Date
August 31, 1997
Primary Completion Date
June 30, 1999
Study Completion Date
June 30, 1999
i. Fixed combination of latanoprost 0.005% and timolol 0.5%
one drop in the morning and placebo in the evening
timolol 0.5% ophthalmic solution
one drop in the morning and evening
latanoprost 0.005% ophthalmic solution
placebo in the morning and latanoprost .005% in the evening
Pfizer Investigational Site, Berlin
Pfizer Investigational Site, Greifswald
Pfizer Investigational Site, Essen
Pfizer Investigational Site, Mülheim
Pfizer Investigational Site, Münster
Pfizer Investigational Site, Coesfeld
Pfizer Investigational Site, Ahaus
Pfizer Investigational Site, Osnabrück
Pfizer Investigational Site, Leverkusen
Pfizer Investigational Site, Gummersbach
Pfizer Investigational Site, Siegburg
Pfizer Investigational Site, Eitorf
Pfizer Investigational Site, Trier
Pfizer Investigational Site, Mainz
Pfizer Investigational Site, Mainz
Pfizer Investigational Site, Mainz
Pfizer Investigational Site, Alzey
Pfizer Investigational Site, Koblenz
Pfizer Investigational Site, Iserlohn
Pfizer Investigational Site, Offenbach
Pfizer Investigational Site, Aschaffenburg
Pfizer Investigational Site, Sulzbach
Pfizer Investigational Site, Leonberg
Pfizer Investigational Site, Freiburg im Breisgau
Pfizer Investigational Site, München
Pfizer Investigational Site, München
Pfizer Investigational Site, Freising
Pfizer Investigational Site, Dillingen
Pfizer Investigational Site, Erlangen
Pfizer Investigational Site, Parsberg
Pfizer Investigational Site, Weiden
Pfizer Investigational Site, Bad Abbach
Pfizer Investigational Site, Hirschaid
Pfizer Investigational Site, Aachen
Pfizer Investigational Site, Aalen
Pfizer Investigational Site, Fulda
Pfizer Investigational Site, Hanover
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
INDUSTRY